Form 4 for BRKR BRUKER CORP
Accepted 2024-03-06 00:00:00 ET · period of report 2024-03-04 · accession 0001415889-24-006998 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-06 | 2024-03-04 | BRKR | Requardt Hermann Fritz | Dir | S - Sale+OE | $90.06 | -15.0K | 23.1K | -39% | -$1.35M |
| DM | 2024-03-06 | 2024-03-04 | BRKR | Requardt Hermann Fritz | Dir | M - OptEx | $22.05 | +15.0K | 28.1K | +114% | +$330.8K |
| DM | 2024-03-06 | 2024-03-04 | BRKR | Requardt Hermann Fritz | Dir | M - OptEx | $0.00 | -15.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-04 | S | D | 13,772 | $90.10 | 24,375 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.70, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-03-04 | M | A | 10,000 | $24.00 | 38,147 | D | — | — | |
| 3 | Common | Common Stock | 2024-03-04 | M | A | 5,000 | $18.15 | 28,147 | D | — | — | |
| 4 | Common | Common Stock | 2024-03-04 | S | D | 1,228 | $89.61 | 23,147 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.60 to $89.64, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Derivative | Stock Option (Right to Purchase) | 2024-03-04 | M | D | 5,000 | $0.00 | 0 | D | $18.15 · — to 2015-08-25 | 5,000 Common Stock | (F3) The stock option granted to the Reporting Person on August 25, 2015 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. |
| 6 | Derivative | Stock Option (Right to Purchase) | 2024-03-04 | M | D | 10,000 | $0.00 | 0 | D | $24.00 · — to 2026-01-05 | 10,000 Common Stock | (F4) The stock option granted to the Reporting Person on January 5, 2016 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. |